TGBA01AD
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameTGBA01AD
Drug Alias Name
Classification
Mechanisms of Action +[4]
Targets +[4]
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFabre-Kramer
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A